Latest news
08-07-2021 - MJFF Alpha-Synuclein Seed Amplification Assay Program - New Request for Applications
Funding to support research that will integrate alpha-synuclein seed amplification assays into clinical studies for the purposes of predicting prognosis, tracking disease progression and monitoring therapeutic response in Parkinson's disease.
Established in 2000, the Michael J Fox Foundation (MJFF) was set up to find a cure for Parkinson's disease (PD) and ensure the development of improved therapies.
[...]